NCT00790400 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 118
- units
- Participants
- groups
- description
- Study drug was given by continuous oral daily dosing of two 5 mg tablets.
- id
- BG000
- title
- Everolimus
- description
- Placebo was given by continuous oral daily dosing of two 5 mg tablets.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.37
- value
- 32.5
- group Id
- BG001
- spread
- 9.64
- value
- 31.0
- group Id
- BG002
- spread
- 10.12
- value
- 32.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 55
- title
- <30 years
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 63
- title
- ≥ 30 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 52
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 78
- title
- Female
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 40
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Gender
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 79
- group Id
- BG001
- value
- 39
- group Id
- BG002
- value
- 118
- units
- Participants
- groups
- description
- Study drug was given by continuous oral daily dosing of two 5 mg tablets.
- id
- BG000
- title
- Everolimus
- description
- Placebo was given by continuous oral daily dosing of two 5 mg tablets.
- id
- BG001
- title
- Placebo
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.37
- value
- 32.5
- group Id
- BG001
- spread
- 9.64
- value
- 31.0
- group Id
- BG002
- spread
- 10.12
- value
- 32.0
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 35
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 55
- title
- <30 years
- categories
- measurements
- group Id
- BG000
- value
- 44
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 63
- title
- ≥ 30 years
- param Type
- NUMBER
- title
- Age, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 52
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 78
- title
- Female
- measurements
- group Id
- BG000
- value
- 27
- group Id
- BG001
- value
- 13
- group Id
- BG002
- value
- 40
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Gender
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle